Latham & Watkins LLP
lw.comlw.comClient SatisfactionLawyers
Michael G. Egge
- Phone+1.202.637.2285
- Email[email protected]
- Profilewww.lw.com
Position
Michael Egge secures regulatory clearances for transformative global transactions and defends clients in high stakes cross-border investigations.
Leveraging more than 30 years of experience and a broad international perspective, Michael advises market leaders on a full spectrum of their most complex antitrust challenges, including investigations of:
-
- Strategic transactions
- Alleged cartel conduct
- Conduct investigations brought by US and European enforcers
Michael is widely regarded for his experience in clearing major transactions that require navigating merger control requirements around the world. He has appeared and argued before antitrust authorities in countries across North America, South America, Europe, and Asia.
A recognized leader at the firm, Michael is Chair of the firm’s Global Antitrust & Competition Practice and has played a pivotal role in building one of the most comprehensive global antitrust practice platforms in the world today. From 2006 to 2015, he led Latham’s Global Antitrust & Competition Practice Group, including three years (2012-2015) resident in the Brussels office, where he helped expand Latham & Watkins’ practice before the European Commission.Michael was Managing Partner of the Washington, D.C. office from 2016 to 2020, and he served on the firm’s Executive Committee from 2020 to 2024.
Michael speaks frequently on antitrust issues and has served in a variety of leadership positions within the American Bar Association’s Antitrust Law Section, including as a member of its governing Council, Co-Chair of the Annual Spring Meeting, Chair of the Merger Process Working Group, and Chair of several of its expert conferences.
He maintains an active pro bono practice, including on behalf of the Osteosarcoma Collaborative, a nonprofit organization for which he is a founding member that brings together data, researchers, patients, and families to find new cures for the disease.